About Kolmar Pharm
Kolmar Pharm is a company based in Seoul (South Korea) founded in 1990 was acquired by IMM Private Equity in May 2020. Kolmar Pharm has completed 1 acquisition, including CSR Cosmetic Solutions. Kolmar Pharm operates in a competitive market with competitors including Crown Laboratories, Encube Ethicals, Famar, Curida and Formulated Solutions, among others.
- Headquarter Seoul, South Korea
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Latest Funding Round
- Investors
-
Employee Count
Employee Count
- Investments & Acquisitions
-
Acquired by
IMM Private Equity
(May 27, 2020)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Kolmar Pharm
Investors in Kolmar Pharm
Kolmar Pharm has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include IMM Investment.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
IMM Investment is recognized as a leading multi-asset alternative investment firm in Asia.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Kolmar Pharm
Kolmar Pharm has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include CSR Cosmetic Solutions.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Cosmetic personal care products are manufactured for various applications.
|
1953 |
Financial Statements - Kolmar Pharm
Kolmar Pharm Comparisons
Competitors of Kolmar Pharm
Kolmar Pharm operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Crown Laboratories, Encube Ethicals, Famar, Curida and Formulated Solutions, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
OTC, prescription, skin care, and oral care products are manufactured.
|
|
| domain | founded_year | HQ Location |
Contract development and manufacturing for topical semisolid formulations are provided.
|
|
| domain | founded_year | HQ Location |
Contract manufacturing and development services provider
|
|
| domain | founded_year | HQ Location |
Liquid pharmaceuticals are developed via blow fill seal technology.
|
|
| domain | founded_year | HQ Location |
Company offering CDMO services for the pharma (Rx and OTC), medical device, personal care and veterinary medicine sectors
|
|
| domain | founded_year | HQ Location |
CDMO focused on manufacturing of semi-solid pharmaceutical drugs
|
Frequently Asked Questions about Kolmar Pharm
Kolmar Pharm was founded in 1990.
Kolmar Pharm is headquartered in Seoul, South Korea.
Kolmar Korea, founded as a joint venture with Nihon (Japan) Kolmar, is a CMO specializing in the development and manufacturing of pharmaceuticals and quasi-drugs. The company offers its services right from the stage of formulation development to right until commercial manufacturing. The company also offers analytics, validation, quality assurance, packaging, and distribution services. The company has capabilities for the development and manufacturing of a range of dosage forms such as ointments, external solutions, syrups, solid dosage forms (tablets, capsules), and quasi-drugs. The company had formed joint ventures with pharmaceutical companies such as Kracie (Japan) and Pharmascience (Canada) in 2012.
Kolmar Pharm's top competitors include Encube Ethicals, Famar and Crown Laboratories.
Kolmar Pharm has made 1 acquisition, including CSR Cosmetic Solutions.
Kolmar Pharm has 1 investor. Key investors include IMM Investment.